LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Recalls and defects › 28 Oct 2025
Medicines recall

Compound Sodium Lactate Solution for Infusion BP (Hartmann’s Solution for infusion) in Viaflo 1000ml

Issued on 28 Oct 2025 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Class 2 recall
Check the batch number on the pack. The medicine remains licensed; other batches are not affected.
Class 2 recall · DMRC-36821405 · PL: 00116/0330 · licence holder: Baxter Healthcare Ltd · active ingredient: potassium chloride, sodium chloride, sodium lactate, calcium chloride dihydrate · licence PL: 00116/0330

What this means

The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.

Class 2 recall · DMRC-36821405

ProductLicenceActive ingredientGTIN
Compound Sodium Lactate Solution for Infusion BP (Hartmann’s Solution for infusion) in Viaflo 1000mlPL: 00116/0330potassium chloride, sodium chloride, sodium lactate, calcium chloride dihydrate05413760142524

Background: Baxter Healthcare is recalling one batch of Compound Sodium Lactate (Hartmann’s Solution) 1000mL. This is due to a packaging error where some cartons within this batch labelled as Hartmann’s Solution may contain Ringer’s Solution 1000mL. This means the wrong product may be inside the box (mixed product in carton). Advice for Healthcare Professionals: Stop supplying the above batch immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.